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Abstract
Background: Urinary tract infection (UTI) is one of the most common bacterial diseases in outpatients and inpatients worldwide.
Treatment of UTI has become challenging due to the emergence of pathogens with increasing resistance to antimicrobial agents.
Objectives: The aim of this study was to determine the prevalence and antimicrobial resistance patterns of main bacteria respon-
sible for UTI.
Methods: In this study, 326 patients with UTI, referring to Shahid Motahari hospital of Fuladshahr, Iran, were evaluated between
March 2015 and February 2016. The isolated bacteria were identified by biochemical tests. Disk diffusion method was applied to
determine the antibiotic sensitivity of bacterial agents.
Results: In a total of 326 positive urine cultures, 273 (83.74%) and 53 (16.25%) samples belonged to females and males, respectively.
The most prevalent isolates were Escherichia coli (58.28%), Klebsiella spp. (11.65%), Staphylococcus spp. (11.65%), Enterobacter spp. (7.05%),
Streptococcus spp. (3.68%), Enterococcus spp. (2.45%), Proteus spp. (1.22%), Pseudomonas spp. (0.61%), and Citrobacter spp. (0.61%), respec-
tively. The antimicrobial susceptibility analysis of E. coli, as the predominant cause of UTI, revealed the following results: gentam-
icin (28.6%), ciprofloxacin (48.4%), nitrofurantoin (12.2%), nalidixic acid (63.7%), trimethoprim/sulfamethoxazole (67.9%), cephalothin
(60%), cefotaxime (44.8%), imipenem (9.5%), amikacin (66.7%), and ampicillin (85.3%).
Conclusions: According to the present survey, E. coli isolates were the predominant pathogens in UTIs and were more prevalent
in women than men. In the present study, the frequency of UTI pathogens was comparable to that reported in previous studies,
showing an increasing resistance pattern to commonly prescribed antibiotics.
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1. Background
Urinary tract infection (UTI) is considered a serious
public health problem. It is the second most common bac-
terial infection, following respiratory tract infections in
the community and hospital settings (1). UTI can be asymp-
tomatic or symptomatic, with a wide range of symptoms
ranging from mild irritative voiding to bacteremia. This
type of infection can lead to an elevated risk of morbidity
and mortality and increased healthcare costs (2-4).
The annual incidence of UTI is nearly 150 - 250 million
people worldwide (5-7). According to previous reports, UTI
is predominant among women. In fact, it is estimated that
half of women will have a UTI during their lifetime (1, 8,
9). Although different microorganisms can cause UTI, Es-
cherichia coli accounts for the overwhelming majority of
UTI cases (approximately 75% of UTI reports) (10, 11).
Treatment of patients with symptomatic UTI is com-
monly achieved through administration of antibiotics,
which can in turn cause alterations in the gut commen-
sal microbiota and eventually lead to the development of
multidrug-resistant microorganisms (5, 10, 11). The preva-
Copyright © 2017, Hamadan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial
4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the
original work is properly cited.
Ghanbari F et al.
lence of antimicrobial resistance among uropathogens,
both in the community and hospital settings, has been in-
creasing worldwide due to different factors, including im-
proper antibiotic use while feeding animals, indiscrimi-
nate prescription of antibiotics, and poor infection control
strategies (4, 7, 12).
Considering the high recurrence rates and emergence
of antibiotic resistance in uropathogens, knowledge about
the area-specific prevalence of these pathogens and their
antimicrobial resistance patterns is necessary (13). Also,
in order to select more appropriate antibiotics and pre-
vent therapeutic failures, it is important to determine
uropathogens and their antibacterial susceptibility pat-
terns (11). With this background in mind, in the present
study, we aimed to determine the prevalence and antimi-
crobial susceptibility patterns of uropathogens among
patients, referring to Shahid Motahari hospital of Fulad-
shahr, Iran.
2. Methods
2.1. Organism Collection and Identification
The present cross sectional study was conducted in
Shahid Motahari hospital of Fuladshahr, Iran during
March 2015 and February 2016. The study population con-
sisted of all inpatients and outpatients with positive urine
cultures. A total of 326 samples with significant bacterial
counts (105 CFU/mL) were recruited during this period.
The isolates were identified and characterized, based
on the standard microbiological tests. For urine culture,
midstream urine samples were collected. The samples
were inoculated within 1 hour of sampling on blood agar
and MacConkey agar. Depending on the microorganism
type, the plates were incubated in both aerobic and anaero-
bic conditions at 37°C for 24 - 48 hours. Standard microbio-
logical tests were conducted, depending on the type of iso-
lated bacteria (Gram-positive or Gram-negative) from var-
ious isolates. In order to identify Gram-negative bacteria,
triple sugar iron (TSI) test, as well as indole, citrate, urea,
lysine decarboxylase, oxidase, and motility tests, was per-
formed. On the other hand, for Gram-positive bacteria,
catalase, coagulase, novobiocin, optochin disk, CAMP, and
esculin agar tests were carried out.
2.2. Antimicrobial Susceptibility Patterns
Antibiotic susceptibility patterns of the isolates were
tested on Mueller-Hinton agar through disk diffusion
method, according to the guidelines by the clinical and
laboratory standards institute (CLSI) (14). The following an-
tibiotics were evaluated in the study: ampicillin (10 µg),
cephalothin (30 µg), ciprofloxacin (5 µg), tetracycline (30
µg), nalidixic acid (30 µg), nitrofurantoin (300 µg), gen-
tamicin (10 µg), trimethoprim/sulfamethoxazole (25 µg),
cefotaxime (5 µg), imipenem (10 µg), amikacin (30 µg),
oxacillin (1 µg), ofloxacin (5 µg), clindamycin (2 µg), ery-
thromycin (15 µg), and vancomycin (30 µg) (HiMedia, In-
dia). In order to classify the samples as resistant or suscep-
tible, the inhibition zone diameter (mm) of each antimi-
crobial disc was measured. Also, E. coli (ATCC25922) was
used as the control strain.
2.3. Statistical Analysis
Data were analyzed using WHONET version 5.6, down-
loaded from the World health organization (WHO) web-
site.
3. Results
A total of 326 patients were evaluated in the present
study, including 273 (83.74%) females and 53 (16.25%) males.
The frequency of isolated bacteria according to sex is pre-
sented in Figure 1. In both male and female subjects, E. coli
(n = 190, 58.28%) was the most commonly isolated microor-
ganism, followed by Klebsiella spp. (n = 38, 11.65%), Staphylo-
coccus spp. (n = 38, 11.65%), Enterobacter spp. (n = 23, 7.05%),
Streptococcus spp. (n = 12, 3.68%), Enterococcus spp. (n = 8,
2.45%), Proteus spp. (n = 4, 1.22%), Pseudomonas spp. (n = 2,
0.61%), and Citrobacter spp. (n = 2, 0.61%), respectively.
Based on the findings, E. coli showed greater sensi-
tivity to imipenem (85.7%), nitrofurantoin (74.5%), and
gentamicin (66.7%) and higher resistance to ampicillin
(85.3%), trimethoprim/sulfamethoxazole (67.9%), and
nalidixic acid (63.7%) (Figure 2). In total, 268 (82.2%) and
58 (17.79%) Gram-negative bacilli and Gram-positive cocci
were isolated from the positive cultures, respectively.
The susceptibility of the isolated bacteria to antimicro-
bials showed significant differences. Based on the antibi-
otic susceptibility test results (Table 1), all the bacteria iso-
lated from UTIs showed the highest level of resistance to
ampicillin and cefotaxime. The Gram-negative bacilli, iso-
lated from UTIs, were sensitive to gentamicin (69.6%) and
nitrofurantoin (67.3%), while Gram-positive cocci were sen-
sitive to nitrofurantoin (86.5%) and ciprofloxacin (62.5%).
In the present study, most of the isolated bacteria were re-
sistant to ampicillin (79.5%) (Table 1).
4. Discussion
UTIs are common bacterial infections, which result in
considerable economic and public health burdens. Ap-
proximately 3.5 billion dollars are annually spent on these
infections in the United States alone. Despite the progress
2 Avicenna J Clin Microb Infec. 2017; 4(3):e42214.
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Figure 1. Frequency and Type of Pathogens Isolated from UTI Samples in Males and Females
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Figure 2. Susceptibility of Microorganisms to Each Antimicrobial Agent
in antimicrobial therapies, UTI remains the leading cause
of mortality (1, 11, 15). The shorter period of antibiotic
therapy, as well as drug administration regardless of the
antimicrobial susceptibility patterns, results in the emer-
gence of resistant strains.
Antibiotic resistance patterns vary in different regions.
In order to apply a suitable treatment strategy in each re-
gion, awareness of dominant pathogens and their sensi-
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Table 1. Antimicrobial Resistance Profile of Bacterial Agents Isolated from UTIs
Organism Resistance Rate, %
TMP-SXT GEN NIT CIP AMP CEP NA TCY CLI VAN OXA OFL IMP
E. coli (n = 190) 128 (67.3) 50 (26.3) 25 (13.0) 95 (50) 157 (82.3) 78 (41.0) 121 (63.6) NA NA NA NA NA 18 (9.5)
Klebsiella spp. (n = 38) 16 (42.1) 8 (21.0) 18 (47.3) 9 (23.6) 38 (100) 17 (44.7) 15 (39.4) NA NA NA NA NA 4 (11)
Staphylococcus spp. (n = 38) 18 (47.3) NA 2 (5.2) NA 25 (65.7) 16 (42.1) NA 24 (63.1) 18 (47.3) 4 (10.5) 25 (65.7) 28 (73.6) NA
Enterobacter spp. (n = 23) 13 (56.5) 8 (34.7) 8 (34.7) 8 (34.7) 17 (73.9) 7 (30.4) 7 (30.4) NA NA NA NA NA NA
Streptococcus spp. (n = 12) 3 (25) NA 5 (41.6) 4 (33.3) 6 (41.6) NA NA 6 (50) 9 (75) 0 (0) NA NA NA
Enterococcus spp. (n = 8) 5 (62.5) NA NA NA 4 (50 NA NA 8 (100) 8 (100) 2 (25) NA 8 (100) NA
Proteus spp. (n = 4) 1 (25 1 (25) 2 (50) 0 (0) 4 (100) 1 (25) 1 (25) NA NA NA NA NA 1 (25)
Yersinia spp. (n = 3) 0 (0) 0 (0) 0 (0) 1 (33.3) NA 2 (66.6) 2 (66.6) NA NA NA NA NA NA
Hafnia spp. (n = 3) 0 (0) 0 (0) 1 (33.3) 0 (0) 2 (66.6) 1 (33.3) NA NA NA NA NA NA NA
Moraxella spp. (n = 3) 0 (0) 0 (0) 0 (0) 1 (33.3) 2 (66.6) 0 (0) 1 (33.3) NA NA NA NA NA NA
Pseudomonas aeruginosa (n = 2) 1 (50) 0 (0) 0 (0) NA 2 (100) NA 2 (100) 0 (0) 1 (50) NA NA NA NA
Citrobacter spp. (n = 2) 2 (100) 0 (0) 2 (100) 1 (50) 2 (100) 1 (50) 1 (50) NA NA NA NA NA NA
Abbreviations: AMP, ampicillin; CEP, cephalothin; CIP, ciprofloxacin; GEN, gentamicin; CLI, clindamycin; IMP, imipenem; NA, nalidixic acid; NA, not applicable; NIT, nitrofurantoin; OFL, ofloxacin; OXA, oxacillin; TCY, tetracycline; TMP-SXT,
trimethoprim/sulfamethoxazole; VAN, vancomycin.
tivity to common antibiotics is essential (13). The present
study was performed with the aim of surveying the preva-
lence of antibiotic resistance patterns of bacterial agents,
isolated from patients with UTI-positive cultures at a hos-
pital in Fuladshahr, Iran.
In the present study, in a total of 326 patients, 273
(83.74%) and 53 (16.25%) cases were female and male, respec-
tively. In accordance with previous studies, prevalence of
UTI was higher among females than males (3, 6, 7). This dif-
ference in the prevalence could be due to several factors, in-
cluding anatomic differences and shorter path to the ure-
thra and vagina, which causes pathogenic bacteria to have
an easier passage to the bladder (5, 6, 16).
In the present study, the most common uropathogen
was E. coli (n = 190, 58.28%), followed by Klebsiella spp. (n
= 38, 11.65%) and Staphylococcus spp. (n = 38, 11.65%). Sim-
ilar observations have been reported in a previous study
(11). Furthermore, in a study by Tajbakhsh et al. E. coli was
identified as the predominant cause of UTIs (51.70%), fol-
lowed by Klebsiella pneumoniae (16.32%) (7). Also, Farajnia et
al. demonstrated that E. coli was the most commonly iso-
lated pathogen in both genders (17).
Klebsiella spp., as the second most common
uropathogen in the present study, showed a high degree of
sensitivity to imipenem, gentamicin, and ciprofloxacin. In
a study by Shanthi and Kayathri, Citrobacter spp. were the
second most frequently isolated bacterial agents (14%) (18).
In general, host-related factors and various environmental
conditions and practices, such as health and educational
programs and socioeconomic standards of sanitation in
each country, can lead to similarities and differences in
the type and distribution of uropathogens (1).
Knowledge of antibiotic resistance patterns in E. coli,
as the predominant causative agent of UTI, is of great im-
portance in selecting an empirical antimicrobial therapy
(19, 20). According to Figure 2 the highest antibiotic re-
sistance of E. coli isolates was reported in drugs, such as
ampicillin (82.63%) and trimethoprim/sulfamethoxazole
(67.9%), which have been used for a long time. The present
results are similar to previous studies conducted in Iran
(13, 21). The most effective antibiotics against E. coli were
imipenem, nitrofurantoin, and gentamicin. Sensitivity to
these antibiotics was reported to be 85.7%, 73.1%, and 68.4%,
respectively (Figure 2).
Imipenem is a carbapenem antibiotic, which is highly
stable against lactamase hydrolysis. This agent is consid-
ered the drug of choice against E. coli, P. aeruginosa, Acineto-
bacter spp., Klebsiella spp., and Enterobacter spp. Although
carbapenem resistance is currently rare among these mi-
croorganisms, its widespread use has led to increased re-
sistance in recent years (22, 23). Although E. coli exhibits
high sensitivity to nitrofurantoin, this antibiotic is not sug-
gested for cases with serious upper urinary tract infections
or systemic involvement (10).
In the present study, sensitivity of E. coli to gentamicin
and nitrofurantoin was less than that reported in other
surveys performed in Iran and other parts of the world (10).
In this regard, in a previous study by Ghorbani et al. E. coli
was more susceptible to ciprofloxacin, amikacin, and ni-
trofurantoin (11). Comparison of the present findings with
previous research showed that the prevalence of gentam-
icin and cephalothin resistance in E. coli isolates was much
lower in our study, compared to the research by Khosh-
bakht et al. in Shiraz, Iran (5).
Furthermore, according to our previous study, con-
ducted during April 2013 and October 2014 in Hamadan,
4 Avicenna J Clin Microb Infec. 2017; 4(3):e42214.
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Iran, E. coli was the most frequent isolate (n = 425,
54.9%), followed by Klebsiella spp. (n = 79, 10.2%). In
this study, the most susceptible antibiotics for the most
prevalent pathogens included nitrofurantoin (n = 24,
5.6%) and amikacin (n = 42, 9.9%). Also, E. coli showed
the highest antibiotic resistance against trimetho-
prim/sulfamethoxazole (n = 278, 65.4%) and nalidixic
acid (n = 235, 55.2%) (24).
4.1. Conclusions
Based on the findings, Gram-negative bacteria were
more often involved in UTIs than Gram-positive bacteria
in the hospital setting. E. coli was the predominant cause
of UTI, while imipenem, nitrofurantoin, and gentamicin
were the most effective antibiotics. Considering the an-
timicrobial susceptibility patterns, in order to reduce the
incidence of UTIs, appropriate use of antibiotics is pro-
posed. Considering the constant variations in the isolates,
UTI causative pathogens, and antibiotic susceptibility pat-
terns, identification of antimicrobial resistance profiles is
suggested in different populations every year.
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